Monte Rosa Therapeutics grants equity awards to four new employees
GLUE•Monte Rosa Therapeutics granted equity awards under its 2026 Inducement Plan to four new non-executive employees, effective November 2, 2026. The awards cover options on 33,775 shares and restricted stock units for 7,400 shares, with vesting conditional on continued service.
1. Equity awards
The options vest 25% on the first grant anniversary, followed by 36 equal monthly installments. The restricted stock units vest 25% on each of the first four grant anniversaries; all awards require continued service through each applicable vesting date.
